Introduction
We have recently reported that the IgG subclass autoantibody response in a large number of fogo selvagem (FS)' patients (n = 32) was preferentially IgG4 (1) . Furthermore, passive 1 . Abbreviations used in this paper: FS, fogo salvagem; ICS, intercellular substance; IF, immunofluorescence; NHS, normal human sera.
transfer experiments carried out with purified FS IgG4 autoantibodies reproduced the human epidermal disease in neonatal mice (1) . The molecular mechanisms by which FS IgG4 autoantibodies trigger keratinocyte detachment (acantholysis) in these animals remains to be determined.
The purpose of the present investigation was twofold. The first purpose was to study the pathogenic effect of proteolytic fragments of FS IgG4 autoantibodies that lack the Fc portion [F(ab')2 and Fab']. This would test the possibility of complement activation via the classical pathway as a mechanism of FS autoantibody injury of keratinocytes. The second purpose was to compare the pathogenic effect of the monovalent FS IgG Fab' fragments with those of intact, undigested FS IgG autoantibodies. This would explore the possibility that the simple binding of a keratinocyte surface antigen by monovalent FS Fab fragments is sufficient to precipitate acantholysis.
Methods
Source of sera. Two FS sera containing high titers of autoantibodies against the epidermal intercellular substance (ICS) were used throughout this investigation (1) . The indirect immunofluorescence (IF) titer of FS autoantibodies in each serum was 1:640. These sera were obtained from two patients with active and generalized disease. Pooled normal human sera (NHS) were used as a source of normal IgG.
Total IgG from FS and NHS was prepared by 40% saturated ammonium sulfate precipitation. The IgG fractions were dissolved with pH 7.2 PBS, treated with protease inhibitors as described previously (1) , and concentrated by ultrafiltration. FS autoantibodies of the IgG4 subclass were prepared from FS IgG by ion exchange chromatography as described previously (1 (1, 5) .
Results
Passive transfer ofFSIgG4 and its F(ab')2 and Fab'fragments induces disease in neonatal mice. All neonatal BALB/c mice injected with FS IgG4 and the F(ab')2 and Fab' fragments derived from the same FS IgG developed disease. These results were reproduced in duplicate littermate animals at least three times for each ofthe antibody fractions. Clinically, the skin of these animals developed extensive erosions, which on histological examination revealed vesicle formation through the granular cell layer. : * * + + + 4 t ' , _ _ > , -% _ _ (10) . Second, this study also shows that FS IgG fragments [Fab' and F(ab')2] which lack the complement binding site are also pathogenic to mice. These findings therefore suggest that in vivo, FS IgG subclasses other than IgG4, present in FS serum, may fix complement to the epidermal ICS and amplify epidermal disease (1 1). This possibility is in agreement with our findings, which showed that mice injected with unfractionated FS IgG developed disease and exhibited murine C3 bound to the epidermal ICS, whereas animals injected with FS IgG4 or its proteolytic fragments also developed epidermal disease but had undetectable murine C3 in the epidermal ICS.
Based on immunoelectron microscopic findings, Patel et al. (12) concluded that the earliest triggering mechanism of acantholysis in pemphigus vulgaris, a close-related disease, is the autoantibody-induced cross-linking of surface antigens.
These complexes are subsequently internalized into intracellular lysosomes. The present investigation, however, showed that this phenomenon may not be relevant in the acantholysis induced by FS autoantibodies because passive transfer of monovalent FS Fab' was far superior than intact FS IgG in inducing epidermal disease in neonatal mice.
As shown in Table I , on the basis of equimolar binding sites, smaller doses of FS Fab' than intact FS IgG were able to induce epidermal disease. Further, the onset of disease in Fab'-injected animals occurred earlier than in mice injected with whole FS IgG. Mice injected with FS Fab' developed disease by 7 h after injection, whereas none of the animals injected with intact FS IgG showed evidence ofdisease by this time. Mice injected with higher doses ofintact FS IgG (7.5 and 15 mg) exhibited epidermal disease only 24 h after the injection. The disease induced by FS Fab' was dose dependent and associated with low titers of human FS autoantibody activity in the mouse sera at 7 h (1:20). This was surprising since relatively higher doses ofintact FS IgG (7.5 and 15 mg) did not induce detectable epidermal disease by 7 h but showed titers of FS autoantibody activity above 1:80 in this same time period. It appears that FS Fab' diffuses from the serum into the epidermal ICS causing disease faster and more efficiently than intact FS IgG molecules. Molecular size or charge may regulate the permeation of these molecules across the basement membrane of the epidermal-dermal junction as suggested by others ( 13) . It has been reported, however, that the clearance of intact human IgG from mouse serum is much slower than Fab' fragments and that elimination of these exogenous proteins is mainly through the kidney (14). Two factors appear to account for the lower titer of FS Fab' at the 7-h diffusion into the epidermal compartment and clearance from the vascular pool. In the animal model, the FS Fab' is rapidly cleared through the kidney and quickly diffuses into the epidermis, resulting in lower titers of autoantibody activity in the mouse serum compared with the intact FS IgG. Intravascular degradation of FS IgG into Fab' fragments does not appear to be relevant to the human disease inasmuch as our studies indicate that intact FS IgG also enters the epidermal compartment and causes acantholysis, but at a much slower rate.
The mechanism by which FS Fab' causes keratinocyte detachment is open to further studies. Binding of a keratinocyte surface molecule appears to play a role in the disease. Borondes (15) listed certain criteria that a molecule should fulfill in order to be considered a cell adhesion molecule. These criteria are: (a) it should be located on the cell surface; (b) the appearance of the cell-surface molecule correlates with the development of adhesiveness; (c) they should have complementary receptors on the cell surface; (d) binding of univalent antibodies (Fab') blocks cell adhesion; and (e) that mutants with impaired cell adhesion should have defective cell adhesion molecule. It is known that FS autoantibodies recognize desmoglein I which is a transmembrane molecule with a surface-exposed domain (16) , and as shown in this study, monovalent FS Fab' induces keratinocyte detachment when passively transferred to neonatal mice. These preliminary observations suggest that the epitopes recognized by FS autoantibodies on the desmoglein molecule may indeed be related to keratinocyte adhesion. FS autoantibodies may bind these epitopes and trigger acantholysis as previously postulated (17, 18) .
